HEADER TRANSFERASE/TRANSFERASE INHIBITOR 26-SEP-13 4MXO TITLE HUMAN SRC KINASE BOUND TO KINASE INHIBITOR BOSUTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 254-536; COMPND 5 SYNONYM: PROTO-ONCOGENE C-SRC, PP60C-SRC, P60-SRC; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SRC, SRC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.M.LEVINSON,S.G.BOXER REVDAT 3 28-FEB-24 4MXO 1 REMARK SEQADV REVDAT 2 05-FEB-14 4MXO 1 JRNL REVDAT 1 04-DEC-13 4MXO 0 JRNL AUTH N.M.LEVINSON,S.G.BOXER JRNL TITL A CONSERVED WATER-MEDIATED HYDROGEN BOND NETWORK DEFINES JRNL TITL 2 BOSUTINIB'S KINASE SELECTIVITY. JRNL REF NAT.CHEM.BIOL. V. 10 127 2014 JRNL REFN ISSN 1552-4450 JRNL PMID 24292070 JRNL DOI 10.1038/NCHEMBIO.1404 REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7_650) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.91 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.970 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 41303 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 2039 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.9120 - 5.1759 0.95 2590 141 0.2391 0.2464 REMARK 3 2 5.1759 - 4.1142 0.99 2728 128 0.1838 0.2309 REMARK 3 3 4.1142 - 3.5959 0.94 2556 134 0.1830 0.2372 REMARK 3 4 3.5959 - 3.2679 0.97 2655 139 0.1969 0.2417 REMARK 3 5 3.2679 - 3.0341 0.98 2654 131 0.2066 0.2544 REMARK 3 6 3.0341 - 2.8555 0.94 2601 130 0.2067 0.2527 REMARK 3 7 2.8555 - 2.7127 0.96 2593 135 0.2201 0.2569 REMARK 3 8 2.7127 - 2.5947 0.97 2637 152 0.2223 0.3015 REMARK 3 9 2.5947 - 2.4949 0.99 2697 141 0.2169 0.2577 REMARK 3 10 2.4949 - 2.4089 0.97 2657 140 0.2110 0.2378 REMARK 3 11 2.4089 - 2.3337 0.92 2473 105 0.2174 0.2495 REMARK 3 12 2.3337 - 2.2670 0.96 2646 148 0.2355 0.2701 REMARK 3 13 2.2670 - 2.2074 0.97 2612 144 0.2397 0.3056 REMARK 3 14 2.2074 - 2.1535 0.97 2665 157 0.2406 0.2897 REMARK 3 15 2.1535 - 2.1050 0.94 2500 114 0.2454 0.2900 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 0.90 REMARK 3 SHRINKAGE RADIUS : 0.61 REMARK 3 K_SOL : 0.41 REMARK 3 B_SOL : 48.00 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.040 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.52270 REMARK 3 B22 (A**2) : -2.76200 REMARK 3 B33 (A**2) : 4.28480 REMARK 3 B12 (A**2) : -0.96320 REMARK 3 B13 (A**2) : -0.23620 REMARK 3 B23 (A**2) : 3.79730 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4452 REMARK 3 ANGLE : 1.080 6035 REMARK 3 CHIRALITY : 0.070 640 REMARK 3 PLANARITY : 0.005 767 REMARK 3 DIHEDRAL : 18.715 1693 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MXO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-OCT-13. REMARK 100 THE DEPOSITION ID IS D_1000082495. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-12 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9198 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41368 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 72.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.14500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.53900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0-4% PEG 3350, 0.2M AMMONIUM ACETATE, REMARK 280 0.1M HEPES PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 248 REMARK 465 HIS A 249 REMARK 465 MET A 250 REMARK 465 GLN A 251 REMARK 465 THR A 252 REMARK 465 GLN A 253 REMARK 465 GLY A 254 REMARK 465 LEU A 255 REMARK 465 ALA A 256 REMARK 465 ASP A 413 REMARK 465 ASN A 414 REMARK 465 GLU A 415 REMARK 465 TYR A 416 REMARK 465 THR A 417 REMARK 465 ALA A 418 REMARK 465 ARG A 419 REMARK 465 GLN A 420 REMARK 465 GLY A 421 REMARK 465 ALA A 422 REMARK 465 LYS A 423 REMARK 465 GLY B 248 REMARK 465 HIS B 249 REMARK 465 MET B 250 REMARK 465 GLN B 251 REMARK 465 THR B 252 REMARK 465 GLN B 253 REMARK 465 GLY B 254 REMARK 465 LEU B 255 REMARK 465 ALA B 256 REMARK 465 LYS B 257 REMARK 465 GLU B 412 REMARK 465 ASP B 413 REMARK 465 ASN B 414 REMARK 465 GLU B 415 REMARK 465 TYR B 416 REMARK 465 THR B 417 REMARK 465 ALA B 418 REMARK 465 ARG B 419 REMARK 465 GLN B 420 REMARK 465 GLY B 421 REMARK 465 ALA B 422 REMARK 465 LYS B 423 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 460 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 259 4.50 -68.96 REMARK 500 GLU A 270 -59.96 -120.92 REMARK 500 PHE A 278 -14.86 -167.65 REMARK 500 SER A 330 31.20 -93.14 REMARK 500 ARG A 385 -0.79 78.24 REMARK 500 ASP A 386 37.93 -144.19 REMARK 500 ARG A 388 166.19 178.06 REMARK 500 ASP A 404 67.22 60.13 REMARK 500 GLU A 486 -0.56 69.20 REMARK 500 HIS B 319 145.02 -170.60 REMARK 500 ARG B 385 -7.90 82.99 REMARK 500 ASP B 386 42.20 -144.32 REMARK 500 ARG B 388 164.23 173.38 REMARK 500 ASP B 404 74.85 53.51 REMARK 500 PRO B 425 109.34 -48.60 REMARK 500 GLU B 486 -6.87 66.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DB8 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DB8 B 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MXX RELATED DB: PDB REMARK 900 HUMAN SRC A403T MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB REMARK 900 RELATED ID: 4MXY RELATED DB: PDB REMARK 900 SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB REMARK 900 RELATED ID: 4MXZ RELATED DB: PDB REMARK 900 SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB DBREF 4MXO A 251 533 UNP P12931 SRC_HUMAN 254 536 DBREF 4MXO B 251 533 UNP P12931 SRC_HUMAN 254 536 SEQADV 4MXO GLY A 248 UNP P12931 EXPRESSION TAG SEQADV 4MXO HIS A 249 UNP P12931 EXPRESSION TAG SEQADV 4MXO MET A 250 UNP P12931 EXPRESSION TAG SEQADV 4MXO GLY B 248 UNP P12931 EXPRESSION TAG SEQADV 4MXO HIS B 249 UNP P12931 EXPRESSION TAG SEQADV 4MXO MET B 250 UNP P12931 EXPRESSION TAG SEQRES 1 A 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 A 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 A 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 A 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 A 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 A 286 VAL MET LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 A 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL THR SEQRES 8 A 286 GLU TYR MET SER LYS GLY SER LEU LEU ASP PHE LEU LYS SEQRES 9 A 286 GLY GLU THR GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 A 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 A 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 A 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 A 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 A 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 A 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 A 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 A 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 A 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 A 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 A 286 MET CYS GLN CYS TRP ARG LYS GLU PRO GLU GLU ARG PRO SEQRES 21 A 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 A 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU SEQRES 1 B 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 B 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 B 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 B 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 B 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 B 286 VAL MET LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 B 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL THR SEQRES 8 B 286 GLU TYR MET SER LYS GLY SER LEU LEU ASP PHE LEU LYS SEQRES 9 B 286 GLY GLU THR GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 B 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 B 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 B 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 B 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 B 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 B 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 B 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 B 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 B 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 B 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 B 286 MET CYS GLN CYS TRP ARG LYS GLU PRO GLU GLU ARG PRO SEQRES 21 B 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 B 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU HET DB8 A 601 36 HET DB8 B 601 36 HETNAM DB8 4-[(2,4-DICHLORO-5-METHOXYPHENYL)AMINO]-6-METHOXY-7-[3- HETNAM 2 DB8 (4-METHYLPIPERAZIN-1-YL)PROPOXY]QUINOLINE-3- HETNAM 3 DB8 CARBONITRILE HETSYN DB8 BOSUTINIB FORMUL 3 DB8 2(C26 H29 CL2 N5 O3) FORMUL 5 HOH *284(H2 O) HELIX 1 1 PRO A 263 GLU A 265 5 3 HELIX 2 2 SER A 303 LEU A 308 1 6 HELIX 3 3 LEU A 308 LEU A 317 1 10 HELIX 4 4 LEU A 346 GLY A 352 1 7 HELIX 5 5 ARG A 359 MET A 380 1 22 HELIX 6 6 ARG A 388 ALA A 390 5 3 HELIX 7 7 GLU A 396 LEU A 398 5 3 HELIX 8 8 ALA A 430 GLY A 437 1 8 HELIX 9 9 THR A 440 THR A 457 1 18 HELIX 10 10 VAL A 467 ARG A 477 1 11 HELIX 11 11 PRO A 488 TRP A 499 1 12 HELIX 12 12 GLU A 502 ARG A 506 5 5 HELIX 13 13 THR A 508 ASP A 518 1 11 HELIX 14 14 ASP A 518 THR A 523 1 6 HELIX 15 15 PRO B 263 GLU B 265 5 3 HELIX 16 16 SER B 303 LEU B 317 1 15 HELIX 17 17 LEU B 346 GLY B 352 1 7 HELIX 18 18 THR B 354 LEU B 358 5 5 HELIX 19 19 ARG B 359 MET B 380 1 22 HELIX 20 20 ARG B 388 ALA B 390 5 3 HELIX 21 21 GLU B 396 LEU B 398 5 3 HELIX 22 22 ALA B 430 GLY B 437 1 8 HELIX 23 23 THR B 440 THR B 457 1 18 HELIX 24 24 VAL B 467 ARG B 477 1 11 HELIX 25 25 PRO B 488 TRP B 499 1 12 HELIX 26 26 GLU B 502 ARG B 506 5 5 HELIX 27 27 THR B 508 ASP B 518 1 11 HELIX 28 28 ASP B 518 THR B 523 1 6 SHEET 1 A 5 LEU A 267 GLN A 275 0 SHEET 2 A 5 GLU A 280 TRP A 286 -1 O MET A 283 N VAL A 271 SHEET 3 A 5 THR A 290 THR A 296 -1 O ILE A 294 N TRP A 282 SHEET 4 A 5 TYR A 335 THR A 338 -1 O ILE A 336 N LYS A 295 SHEET 5 A 5 LEU A 325 VAL A 329 -1 N TYR A 326 O VAL A 337 SHEET 1 B 3 GLY A 344 SER A 345 0 SHEET 2 B 3 ILE A 392 VAL A 394 -1 O VAL A 394 N GLY A 344 SHEET 3 B 3 CYS A 400 VAL A 402 -1 O LYS A 401 N LEU A 393 SHEET 1 C 2 TYR A 382 VAL A 383 0 SHEET 2 C 2 ARG A 409 LEU A 410 -1 O ARG A 409 N VAL A 383 SHEET 1 D 5 LEU B 267 GLY B 276 0 SHEET 2 D 5 GLY B 279 TRP B 286 -1 O GLY B 279 N GLY B 276 SHEET 3 D 5 THR B 290 THR B 296 -1 O THR B 296 N GLU B 280 SHEET 4 D 5 TYR B 335 THR B 338 -1 O ILE B 336 N LYS B 295 SHEET 5 D 5 LEU B 325 VAL B 329 -1 N TYR B 326 O VAL B 337 SHEET 1 E 3 GLY B 344 SER B 345 0 SHEET 2 E 3 ILE B 392 VAL B 394 -1 O VAL B 394 N GLY B 344 SHEET 3 E 3 CYS B 400 VAL B 402 -1 O LYS B 401 N LEU B 393 SHEET 1 F 2 TYR B 382 VAL B 383 0 SHEET 2 F 2 ARG B 409 LEU B 410 -1 O ARG B 409 N VAL B 383 CISPEP 1 GLU A 332 PRO A 333 0 -7.06 CISPEP 2 GLU B 332 PRO B 333 0 -1.45 SITE 1 AC1 17 LEU A 273 ALA A 293 ILE A 294 LYS A 295 SITE 2 AC1 17 GLU A 310 MET A 314 VAL A 323 ILE A 336 SITE 3 AC1 17 THR A 338 GLU A 339 TYR A 340 MET A 341 SITE 4 AC1 17 SER A 342 LEU A 393 ASP A 404 HOH A 742 SITE 5 AC1 17 HOH A 754 SITE 1 AC2 17 LEU B 273 ALA B 293 ILE B 294 LYS B 295 SITE 2 AC2 17 GLU B 310 VAL B 323 ILE B 336 THR B 338 SITE 3 AC2 17 GLU B 339 TYR B 340 MET B 341 SER B 342 SITE 4 AC2 17 GLY B 344 LEU B 393 ASP B 404 HOH B 745 SITE 5 AC2 17 HOH B 825 CRYST1 41.870 63.185 73.665 79.53 89.31 90.05 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023883 0.000019 -0.000298 0.00000 SCALE2 0.000000 0.015827 -0.002925 0.00000 SCALE3 0.000000 0.000000 0.013806 0.00000